Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patients.

J Neurol

Assistance Publique-Hôpitaux de Paris (AP-HP), Service de neurologie, de l'Hôpital Avicenne, 125 route de Stalingrad, 93009, Bobigny, France.

Published: March 2016

Glioblastoma patients often require chronic administration of steroids due to peri-tumoral edema. Preliminary studies showed that treatment with Angiotensin-II Receptor Blockers (ARBs) for high blood pressure might be associated with reduced peri-tumoral edema. In this study, we aim to radiologically assess the effect of ARBs on peri-tumoral edema. We conducted a cross-sectional survey on patients with newly diagnosed GBM. Patients treated with ARBs for high blood pressure were paired to non ARB-treated patients based on similar age, tumor location and tumor size. Patients taking steroids at the time of pre-operative Magnetic Resonance Imaging were excluded from the study. In each pair of patients, we compared the volumes of peri-tumoral hyper T2-Fluid Attenuated Inversion Recovery (FLAIR) signal and the Apparent Diffusion Coefficient (ADC) in the same area. Eleven (11) ARB-treated patients were selected and paired to 11 non ARB-treated controls. Volumes of peri-tumoral hyper T2-FLAIR signal were significantly lower in the ARB-treated group than in the non ARB-treated group (p = 0.02). Additionally, peri-tumoral ADCs were also significantly lower in the treated group (p = 0.02), suggesting that the peri-tumoral area in this group had less edematous features. These results suggest that ARBs may reduce the volume of peri-tumoral hyper T2-FLAIR signal by decreasing edema.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-015-8016-9DOI Listing

Publication Analysis

Top Keywords

peri-tumoral edema
12
peri-tumoral hyper
12
angiotensin-ii receptor
8
receptor blockers
8
patients
8
glioblastoma patients
8
peri-tumoral
8
arbs high
8
high blood
8
blood pressure
8

Similar Publications

Article Synopsis
  • Glioblastoma (GBM) is an aggressive brain tumor that often infiltrates beyond its visible boundaries, making treatment challenging with standard surgical and chemoradiotherapy approaches.
  • A new method was developed that combines expert insights and data augmentation to improve predictions of tumor infiltration using preoperative magnetic resonance imaging (mpMRI) scans from 229 patients.
  • The model was validated through cross-institutional tests, showing varying effectiveness in predicting tumor recurrence, with odds ratios indicating strong potential for guiding targeted treatment strategies.
View Article and Find Full Text PDF

Peritumoral edema enhances MRI-based deep learning radiomic model for axillary lymph node metastasis burden prediction in breast cancer.

Sci Rep

August 2024

Department of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, No. 55, 4th Section of South Ren-Min Road, Chengdu, 610041, China.

To investigate whether peritumoral edema (PE) could enhance deep learning radiomic (DLR) model in predicting axillary lymph node metastasis (ALNM) burden in breast cancer. Invasive breast cancer patients with preoperative MRI were retrospectively enrolled and categorized into low (< 2 lymph nodes involved (LNs+)) and high (≥ 2 LNs+) burden groups based on surgical pathology. PE was evaluated on T2WI, and intra- and peri-tumoral radiomic features were extracted from MRI-visible tumors in DCE-MRI.

View Article and Find Full Text PDF

Purpose: Supratentorial (ST) ependymoma subgroups are defined by two different fusions with different prognoses. Astroblastomas, MN1-altered, have ependymal-like histopathologic features and represent a differential diagnosis in children. We hypothesized that ZFTA-fused ependymoma and YAP1-fused ependymoma on the one hand, and astroblastoma, MN1-altered, on the other hand, show different MRI characteristics.

View Article and Find Full Text PDF

Background: Neo-adjuvant chemotherapy (NACT) followed by response assessment is the standard treatment algorithm for locally advanced oral cavity squamous cell carcinomas (OCSCC) in the Indian subcontinent. The 3-drug NACT regimen (Docetaxel-Cisplatin-5-FU) has shown improvement in overall survival over 2-drug regimen (Docetaxel-Cisplatin) in a phase-3 randomised study. We have analysed the 10-year outcomes with this treatment algorithm.

View Article and Find Full Text PDF

Supratentorial hemangioblastomas are rare, vascular lesions. The presence of peri-tumoral cysts and edema has meaningful clinical, diagnostic and therapeutic implications. Nevertheless, the pathogenesis of both cyst and edema formation is not fully understood.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!